Table 1.

Patient characteristics

n% (range)
No. patients evaluable29100
Primary sites (histology)*
    Lung
        Non–small cell lung cancer620.7
        Small cell lung cancer26.9
    Head and neck
        Squamous cell carcinoma517.2
    Breast
        Infiltrating ductal310.3
        Infiltrating lobular13.4
    Colon/rectum
        Adenocarcinoma413.8
    Renal
        Chromophobe13.4
        Clear cell13.4
        Papillary adenocarcinoma13.4
    Sarcoma extremity
        Malignant fibrous histiocytoma310.3
    Uterine
        Leiomyosarcoma13.4
    Ovary
        Papillary serous13.4
No. metastatic lesions treated56100%
    No. lung lesions1832%
    No. liver lesions916%
    No. nodal lesions1323%
    No. osseous lesions916%
    No. adrenal lesions611%
    No. soft tissue masses12%
Mean no. sites per patients2(1-5)
No. exposed to systemic therapy before protocol radiotherapy2481%
Mean no. courses of systemic therapy1.7(0-9)
Mean no. systemic agents exposed to2.5(0-11)
  • * Numbers do not add to 100% due to rounding.